Theleme Partners LLP
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), Theleme Partners LLP reported 11 stock positions worth $1.5 billion. Its top holding was Moderna (MRNA) at 20.4% of the portfolio, followed by Bank of America (BAC, 17.7%) and Wells Fargo (WFC, 12.5%). Compared with Q3 2024, it opened 4 new positions, sold out of 3, added to 3 and reduced 2. The biggest buy was a new position in Bank of America (BAC) and the biggest sale an exit from Schwab (charles) (SCHW).
- Most Recent 13F
- Q2 2026
- Location
- London, X0
- CIK
- 0001511881
- Portfolio Value
- $1.5B (Q4 2024)
- SEC Filing
- 0000919574-25-001195 ↗ filed Feb 14, 2025
Holdings Value
Holdings 11 stocks · $1.5B
| MRNA Moderna Inc. | 20.36% | 7,306,861 | $303.8M | Add +1.1% |
| BAC Bank of America Corp. filed as BANK AMERICA CORP | 17.66% | 5,994,300 | $263.4M | New |
| WFC Wells Fargo & Co. | 12.54% | 2,663,000 | $187.0M | New |
| AMZN Amazon.com Inc. | 12.50% | 850,000 | $186.5M | Add +28.8% |
| EFX Equifax Inc. | 12.18% | 713,088 | $181.7M | Add +19.2% |
| TRU Transunion | 9.20% | 1,480,357 | $137.2M | Reduce -32.9% |
| SKX Skechers USA Inc. Class A | 7.01% | 1,555,000 | $104.6M | No change |
| UBER Uber Technologies Inc. | 5.07% | 1,253,750 | $75.6M | New |
| HDB HDFC Bank Ltd.-ADR | 2.14% | 500,800 | $32.0M | Reduce -2.5% |
| SONY Sony Group Corp. - SP ADR | 1.31% | 925,000 | $19.6M | No change |
| SARO Standardaero Inc. | 0.03% | 20,000 | $495K | New |
Portfolio Sells Q3 2024 → Q4 2024
Portfolio Buys Q3 2024 → Q4 2024
Options Activity Q3 2024 → Q4 2024
| MRNA Moderna Inc. | call | Sold out | 7,972 | $53.3Mbefore exit |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 9 | $1.7B | MRNA, META, UBER, AMZN, TRU |
| Q1 2026 | 9 | $1.5B | MRNA, META, UBER, TRU, AMZN |
| Q4 2025 | 9 | $1.5B | META, MRNA, FLUT, TRU, WFC |
| Q3 2025 | 10 | $1.6B | META, WFC, MRNA, TRU, UBER |
| Q2 2025 | 10 | $1.6B | MRNA, WFC, META, TRU, FLUT |
| Q1 2025 | 12 | $1.3B | MRNA, AMZN, WFC, TRU, EFX |
| Q4 2024 | 11 | $1.5B | MRNA, BAC, WFC, AMZN, EFX |
| Q3 2024 | 10 | $1.7B | MRNA, SCHW, TRU, EFX, HRI |
| Q2 2024 | 8 | $2.0B | MRNA, SCHW, WFC, TRU, HRI |
| Q1 2024 | 7 | $1.8B | MRNA, SCHW, WFC, HRI, TRU |